139755-80-9NC(N)=NCc1cccc([123I])c1.NC(N)=NCc1cccc([123I])c1.O=S(=O)(O)OXNACDNPGABUBFR-FKNPGSCZSA-NIobenguane sulfate I-123 is a radiopharmaceutical used in gamma-scintigraphy of adrenergically inervated tissues.
139755-80-9、80663-95-2CHEMBL3989523FDA approved drugs -> Active ingredient
FDA approved drugs -> Active ingredient
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Iobenguane I-123 is transported into adrenergic nerve terminals via the noradrenaline uptake transporter. It is rapidly cleared from systemic circulation and collected in adrenergically invervated tissues. This allows for gamma-scintigraphic imaging of these tissues and their associated organs for diagnostic purposes.
23X1185WBO
IOBENGUANE SULFATE I-123
Established Pharmacologic Class [EPC] - Radioactive Diagnostic Agent
Mechanisms of Action [MoA] - Radiopharmaceutical Activity
Iobenguane sulfate i-123 is a Radioactive Diagnostic Agent. The mechanism of action of iobenguane sulfate i-123 is as a Radiopharmaceutical Activity.
Primarily eliminated via the urine as the parent compound (70-90%). A small amount is eliminated in the urine as m-iodohippuric acid (</10%) and free radioiodide (</6%). Less than 1% is eliminated in the feces. Iobenguane I-123 is initially rapidly cleared from circulation follwed by a slow clearance from other tissues over 4 days. Retention is the longest in highly adrenergically inervated tissues like the adrenal medulla, heart, and salivary glands. Iobenguane I-123 is not cleared by dialysis.
VerwendenRadioactive agent.
Keine Reaktionsaufzeichnungen unter den aktuellen Filterkriterien.
Wird geladen…